Drug Utilization

Drug Utilization

HCF P&T Committee

The Pharmacy and Therapeutics (P&T) Committee

The P&T Committee provides recommendations for the Medicaid Preferred Drug List (PDL). The Committee is composed of Physicians & Pharmacists who meet at least quarterly to consider PDL implementation. These meetings are generally scheduled on the third Friday of every month at 7:00 A.M. in the Cannon Health Building at 288 N. 1460 W. in Salt Lake City, UT.

The P&T Committee reserves the right to adjust the meeting schedule as necessary. Notices for exact meeting times and locations will be published in the Legal Notices sections of the Salt Lake Newspapers at least 24 hours in advance.

The meetings are open to the public.

Public Comments for the P&T Committee:

Public comment that responds to the materials presented by the Drug Information Service at the University of Utah is most helpful. The foundation documents used for most reviews are prepared by the Oregon Evidence-Based Practice Center or the Drug Information Service and are posted in advance on the P&T Committee website

Manufacturers are requested to submit any additional materials they would like reviewed as part of the process to:

Drug Information Service
Attn: Linda Tyler, PharmD
University of Utah Hospitals & Clinics
421 Wakara Way, Suite 204
Salt Lake City, UT 84108

All materials must be clearly labeled that they are submitted for consideration as part of the State of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible) after the Oregon monograph was prepared, unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search.

Persons who wish to address the P&T Committee may contact Duane Parke at 538-6841 at least 7 calendar days prior to the meeting. Comments from visitors, while welcome, may be limited due to time constraints

Listed below is a P&T Committee class review schedule. Criteria review documents can be found in the library located below the schedule. :


May. 08 Asthma Drugs-Inhaled Corticosteroids
Jun. 08 Asthma Drugs-Leukotriene Antagonists
Jul. 08 Sedative Hypnotics
Aug. 08 Insulins - Rapid Acting
Sep. 08 Insulins - Mixtures & Long Acting

Listed below are meeting minutes, agendas, and reports regarding the P&T Committee:

The documents are provided in Adobe format. If you cannot view a file, please download the free plug-in from the link below.

pdf   Acrobat Viewer

Name Type Last Modified
Criteria Review DocumentsFolder May 08, 2008
Draft Future AgendasFolder April 23, 2008
MinutesFolder April 23, 2008